Login / Signup

Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial.

Li-Xin PanYi-Yang WangZhong-Hai LiJia-Xi LuoKun-Jun WuZhen-Xiu LiuPei-Sheng WuKang ChenLiang MaXiao-Hui FanJian-Hong Zhong
Published in: Trials (2024)
ClinicalTrials.gov NCT02650271. Registered on January 7, 2016.
Keyphrases
  • hepatitis b virus
  • open label
  • phase iii
  • phase ii
  • study protocol
  • clinical trial
  • liver failure
  • phase ii study
  • rectal cancer
  • randomized controlled trial
  • antiretroviral therapy
  • prognostic factors
  • double blind